Mainstream Capital Management’s Eli Lilly LLY Stock Holding History

Mainstream Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.7M	Sell	2,250 -42	-2%	-$42.9K	1.63%	15
2026 Q1	$2.11M	Buy	2,292 +6	+0.3%	+$6.08K	1.41%	19
2025 Q4	$2.46M	Sell	2,286 -32	-1%	-$30.6K	1.61%	16
2025 Q3	$1.77M	Buy	2,318 +20	+0.9%	+$14.9K	1.18%	22
2025 Q2	$1.79M	Buy	2,298 +668	+41%	+$519K	1.3%	20
2025 Q1	$1.35M	Buy	1,630 +1,361	+506%	+$1.13M	1.07%	29
2024 Q4	$208K	Hold	269	–	–	0.15%	87
2024 Q3	$238K	Buy	+269	New	+$242K	0.2%	80

Other funds holding LLY

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Mainstream Capital Management's LLY Position: Q2 2026 in Review

Mainstream Capital Management reduced its Eli Lilly (LLY) stake by 1.8% in Q2 2026, selling an estimated $42.9K and leaving 2,250 shares worth $2.7M. The position accounts for 1.63% of the portfolio, ranked #15.

Mainstream Capital Management first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 961 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Mainstream Capital Management held 2,250 shares of Eli Lilly worth $2.7M as of Q2 2026.
Mainstream Capital Management sold 42 Eli Lilly shares in Q2 2026, an estimated $42.9K.
Eli Lilly made up 1.63% of Mainstream Capital Management's portfolio in Q2 2026, its #15 holding.
Mainstream Capital Management first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
961 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mainstream Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.